Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05018208 · ClinicalTrials.gov registry record

Remote Monitoring in Cancer Care: A Platform Study

A clinical trial, sponsored by Mayo Clinic.

Completed
Registry status
100
Enrollment target

NCT05018208: Completed study, sponsored by Mayo Clinic.

NCT05018208 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT05018208 has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
100 participants
Enrollment target

Study Summary

This study investigates a device that closely monitors vital signs, as well as a smartphone application (app) that allows patients to respond to different questions and tests that will monitor for new symptoms. This study may help researchers understand if wearing the device is a better tool than standard vital sign assessment tools done only while at the doctor's office or hospital, and if using the smartphone app is a better tool than standard assessment tools used while in the doctor's office or hospital.

Interventions

  • OTHER Questionnaire Administration
  • PROCEDURE Patient Monitoring
  • OTHER Computer-Assisted Intervention

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2021-12-15
Est. Completion 2025-04-17
Mayo Clinic

2,844 total trials

What the finished NCT05018208 record still lists

NCT05018208 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 3 interventions - of which Questionnaire Administration is the first listed.

NCT05018208 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05018208 about?

NCT05018208 is a clinical study titled "Remote Monitoring in Cancer Care: A Platform Study". This study investigates a device that closely monitors vital signs, as well as a smartphone application (app) that allows patients to respond to different questions and tests that will monitor for new symptoms. This study may help researchers understand if wearing the device is a better tool than st...

What is the current status of trial NCT05018208?

This trial is currently completed. The enrollment target is 100 participants. The study started on 2021-12-15. Estimated completion is 2025-04-17.

What interventions are being tested in trial NCT05018208?

The interventions under investigation include: Questionnaire Administration (OTHER), Patient Monitoring (PROCEDURE), Computer-Assisted Intervention (OTHER).

Who is sponsoring clinical trial NCT05018208?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05018208, the US trial registry maintained by the National Library of Medicine. NCT05018208 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.